Colchicine has been utilized safely in a variety of cardiovascular clinical conditions. Among its potential mechanisms of action is the non-selective inhibition of NLRP3 inflammasome which is thought to be a major pathophysiologic component in the clinical course of patients with COVID-19. GRECCO-19 will be a prospective randomized open-labeled controlled study to assess the effects of colchicine in COVID-19 complications prevention. The Greek study in the effects of colchicine in COvid-19 complications prevention GRECCO-19 study: Rationale and study design.